Supriya Lifescience Ltd


Supriya Lifescience Ltd

Health CarePharmaceuticals and Biotechnology
  • Price (INR)205.55
  • Today's Change-9.95 / -4.62%
  • Shares traded217.58k
  • 1 Year change-55.70%
  • Beta--
Data delayed at least 15 minutes, as of Feb 01 2023 10:19 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • SUPRIYA:NSI price reached a new 52-week low of 207.50 at 14:29 GMT
  • SUPRIYA:NSI price reached a new 52-week low of 209.00 at 12:32 GMT
  • SUPRIYA:NSI price moved over -1.97% to 209.00
  • SUPRIYA:NSI trading volume exceeds daily average by +17.84%

Key statistics

Supriya Lifescience Ltd (SUPRIYA:NSI) set a new 52-week low during today's trading session when it reached 203.25. Over this period, the share price is down -57.35%.
52-week range
203.25Feb 01 2023516.00Mar 31 2022
Previous close215.50
Average volume120.54k
Shares outstanding80.48m
Free float20.98m
P/E (TTM)13.55
Market cap17.34bn INR
EPS (TTM)15.91
Annual div (ADY)0.600
Annual div yield (ADY)0.28%
Div ex-dateSep 01 2022
Div pay-dateOct 16 2022
Data delayed at least 15 minutes, as of Feb 01 2023 10:19 GMT.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.